A28 Therapeutics Revenue

Biotechnology Research • San Diego, California, United States • 1-10 Employees

A28 Therapeutics revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contact at A28 Therapeutics

Carola Leuschner

Vice President, Research and Development

Company overview

Headquarters	San Diego, California, United States
Website	a28therapeutics.com
NAICS	541714
Keywords	Oncology, Biotech, Cancer Research, Liver Cancer, Ovarian Cancer, Solid Tumors, Metastatic Cancer, Lytic Peptides For Cancer, Oncolytic Peptides
Founded	2021
Employees	1-10
Socials

A28 Therapeutics Email Formats

A28 Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@a28therapeutics.com), used 50% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@a28therapeutics.com	50%
{first name}.{last name}	john.doe@a28therapeutics.com	50%

About A28 Therapeutics

A28 Therapeutics is a privately-held, clinical-stage biopharmaceutical company focused on the development of its targeted oncolytic peptide platform for the treatment of multiple cancer types. Our lead proprietary agent, AT-101, has demonstrated the potential to deliver safe and effective cancer treatment alone and in combination with multiple classes of cancer medications including immuno-oncology medications and chemotherapy. Our lead indications are metastatic ovarian cancer with liver metastases and hepatocellular carcinoma, and we are in late-stage development in both indications. In addition, A28 is preparing to study the benefits of AT-101 in combination with immuno-oncology therapeutics in various solid tumors with liver metastases. Our goal at A28 is to deliver innovative, game-changing cancer care to patients worldwide.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Vice President

Employees by Department

A28 Therapeutics has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

A28 Therapeutics has never raised funding before.

A28 Therapeutics Tech Stack

Discover the technologies and tools that power A28 Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

SiteGround

Hosting

Site Kit

Analytics

Vimeo

Video players

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

YouTube

Video players

Frequently asked questions

A28 Therapeutics is located in San Diego, California, US.

A28 Therapeutics generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

A28 Therapeutics has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

A28 Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

A28 Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at A28 Therapeutics

Carola Leuschner

Vice President, Research and Development

4.8

40,000 users